197 related articles for article (PubMed ID: 22051143)
21. Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA.
Mori T; Crandall CJ; Ganz DA
Osteoporos Int; 2017 Feb; 28(2):585-595. PubMed ID: 27726000
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes.
van Giessen A; Boonman-de Winter LJ; Rutten FH; Cramer MJ; Landman MJ; Liem AH; Hoes AW; Koffijberg H
Cardiovasc Diabetol; 2016 Mar; 15():48. PubMed ID: 27001409
[TBL] [Abstract][Full Text] [Related]
23. Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation.
Retèl VP; Steuten LMG; Geukes Foppen MH; Mewes JC; Lindenberg MA; Haanen JBAG; van Harten WH
BMC Cancer; 2018 Sep; 18(1):895. PubMed ID: 30219040
[TBL] [Abstract][Full Text] [Related]
24. Protons in head-and-neck cancer: bridging the gap of evidence.
Ramaekers BL; Grutters JP; Pijls-Johannesma M; Lambin P; Joore MA; Langendijk JA
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1282-8. PubMed ID: 23273998
[TBL] [Abstract][Full Text] [Related]
25. Value of information: interim analysis of a randomized, controlled trial of goal-directed hemodynamic treatment for aged patients.
Bartha E; Davidson T; Brodtkorb TH; Carlsson P; Kalman S
Trials; 2013 Jul; 14():205. PubMed ID: 23837606
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness analysis of an 18-week exercise programme for patients with breast and colon cancer undergoing adjuvant chemotherapy: the randomised PACT study.
May AM; Bosch MJ; Velthuis MJ; van der Wall E; Steins Bisschop CN; Los M; Erdkamp F; Bloemendal HJ; de Roos MA; Verhaar M; Ten Bokkel Huinink D; Peeters PH; de Wit GA
BMJ Open; 2017 Mar; 7(3):e012187. PubMed ID: 28264824
[TBL] [Abstract][Full Text] [Related]
27. Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland.
Soini E; Virtanen O; Väätäinen S; Briere JB; Bowrin K; Millier A
Adv Ther; 2020 Jul; 37(7):3348-3369. PubMed ID: 32519113
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of neck-specific exercise with or without a behavioral approach versus physical activity prescription in the treatment of chronic whiplash-associated disorders: Analyses of a randomized clinical trial.
Landén Ludvigsson M; Peolsson A; Peterson G; Dedering Å; Johansson G; Bernfort L
Medicine (Baltimore); 2017 Jun; 96(25):e7274. PubMed ID: 28640136
[TBL] [Abstract][Full Text] [Related]
29. Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer.
Lam SW; Wai M; Lau JE; McNamara M; Earl M; Udeh B
Pharmacotherapy; 2017 Jan; 37(1):94-103. PubMed ID: 27870079
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of endovascular repair, open repair, and conservative management of splenic artery aneurysms.
Hogendoorn W; Lavida A; Hunink MG; Moll FL; Geroulakos G; Muhs BE; Sumpio BE
J Vasc Surg; 2015 Jun; 61(6):1432-40. PubMed ID: 25827968
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of health coaching and financial incentives to promote physical activity after total knee replacement.
Smith KC; Paltiel AD; Yang HY; Collins JE; Katz JN; Losina E
Osteoarthritis Cartilage; 2018 Nov; 26(11):1495-1505. PubMed ID: 30092263
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in Sweden.
Srivastava T; Prabhu VS; Li H; Xu R; Zarabi N; Zhong Y; Pellissier JM; Perini RF; de Wit R; Mamtani R
Eur Urol Oncol; 2020 Oct; 3(5):663-670. PubMed ID: 31412001
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness analysis of proton beam therapy for treatment decision making in paranasal sinus and nasal cavity cancers in China.
Li G; Qiu B; Huang YX; Doyen J; Bondiau PY; Benezery K; Xia YF; Qian CN
BMC Cancer; 2020 Jun; 20(1):599. PubMed ID: 32590957
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer.
Sher DJ; Tishler RB; Annino D; Punglia RS
Ann Oncol; 2010 May; 21(5):1072-7. PubMed ID: 19833820
[TBL] [Abstract][Full Text] [Related]
35. Analyzing cost-effectiveness of ulnar and median nerve transfers to regain forearm flexion.
Wali AR; Park CC; Brown JM; Mandeville R
Neurosurg Focus; 2017 Mar; 42(3):E11. PubMed ID: 28245686
[TBL] [Abstract][Full Text] [Related]
36. Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma.
Sher DJ; Tishler RB; Pham NL; Punglia RS
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):875-882. PubMed ID: 29976499
[TBL] [Abstract][Full Text] [Related]
37. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
[TBL] [Abstract][Full Text] [Related]
38. Economic evaluation of a group-based exercise program for falls prevention among the older community-dwelling population.
McLean K; Day L; Dalton A
BMC Geriatr; 2015 Mar; 15():33. PubMed ID: 25879871
[TBL] [Abstract][Full Text] [Related]
39. Economic evaluation of temozolomide in the treatment of recurrent glioblastoma multiforme.
Martikainen JA; Kivioja A; Hallinen T; Vihinen P
Pharmacoeconomics; 2005; 23(8):803-15. PubMed ID: 16097842
[TBL] [Abstract][Full Text] [Related]
40. Cetuximab plus radiotherapy for the treatment of locally advanced squamous cell carcinoma of the head and neck.
Griffin S; Walker S; Sculpher M; White S; Erhorn S; Brent S; Dyker A; Ferrie L; Gilfillan C; Horsley W; Macfarlane K; Thomas S
Health Technol Assess; 2009 Jun; 13 Suppl 1():49-54. PubMed ID: 19567214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]